1/72
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No study sessions yet.
Iron rich foods
Fruits
Dark chocolate
broccoli
red meat
legumes
leafy greens
whole grains
tofu
pumpkin seeds
Vitamin B12 rich foods
fortified cereals
Shitake mushrooms
boiled eggs
sardines
chicken
Folate rich foods
spinach
broccoli
lettuce
peas
beans
lentils
watermelon
orange juice
bananas
lemons
cereal
bread
Hematopoiesis
blood cell formation
Myeloid stem cells:
RBC, WBC, platelets
Lymphoid stem cells:
B or T lymphocytes
Erythrocytes
RBC
Leukocytes
- WBC
Thrombocytes-
Platelets
Plasma
90% water, contains plasma proteins and clotting factors
Red Blood Cells
“Feed” the cells of the body
• Transport O2 and CO2
• Removed by the liver and spleen
• Hematocrit
• The volume of blood composed of RBC’s.
• Hemoglobin
• 95% of RBC mass, carries O2
White Blood Cells
“Defend” the cells of the body
Fight infection
Types of Cells:
• Neutrophil: prevent or limit bacterial infections
• Monocytes: Enter tissue as a macrophage, highly phagocytic (destroy)
• Eosinophils: involved in allergic reactions
• Basophil: contain histamines
Platelets
“Heal” the body
Increased RBC, HCT, HGB:
Polycythemia or erythrocytosis, Chronic anoxia
Decreased RBC, HCT, HGB:
Anemia or blood loss, bone marrow suppression
Increased WBC
Infection, inflammation, leukemia
Decreased WBC
Prolonged infection or bone marrow depression
Increased Serum Fe
Liver disorders, megaloblastic anemia
Decreased Serum Fe
Iron-deficiency anemia, hemorrhage
Increased Platelet
Thrombocytosis
Decreased Platelet
Suppressed bone marrow function, splenomegaly
Increased PT
Deficiencies in Clotting factor V and VII, oral anticoagulant therapy
Decreased PT
Vitamin K excess
PTT (aPTT is 25-35 seconds):
• Monitors response to Heparin, monitors intrinsic pathway clotting factors
Bone Marrow Aspiration and Biopsy
NURSING ACTIONS:
- Teach about brief pain and pressure
- Ensure the client avoided anticoagulants before the procedure and that consent is signed
- Put the patient in a prone or side-lying position
- Post-procedure, maintain bedrest for 30 min to an hour
- Check for bleeding every 2 hours for 24 hours
- Removal of sutures is after 7-10 days
- Analgesics for pain *not Aspirin
Potential Complications: Bone marrow aspiration and Biopsy
Infection at the site
- Apply a sterile dressing
- Watch for S/S of infection
Risk for bleeding
Bedrest for 30-60 min after the test
Apply pressure at the site, pressure dressing
Apply ice
Therapeutic Procedures
Splenectomy
Apheresis (Table 28-3)
Hematopoietic Stem Cell Transplantation
Phlebotomy
Types of Blood Donation
Standard
Autologous:
• Patients own blood, collected 4-6 weeks prior to procedure, give iron supplements, can donate 1 unit per week but not within 72 hours of procedure
Intraoperative Blood Salvage (Cell Saver)
Autologous Blood donation
• Patients own blood, collected 4-6 weeks prior to procedure, give iron supplements, can donate 1 unit per week but not within 72 hours of procedure
Febrile Nonhemolytic transfusion reaction
• Chills
• 1° C elevation temperature (at least)
• Typically begins within 1 hour of the transfusion
*Acute Hemolytic Transfusion reaction
• Most dangerous
• Incompatible blood
• Fever
• Chills
• Dyspnea
• Low back pain
• Nausea
• Anxiety
• Hypotension
• Bronchospasm
• Hemoglobinuria
• Vascular collapse
Allergic transfusion reaction
• Hives
• Flushing
• Wheezing
• Decreased BP
• Increased anxiety
Treatment for transfusion reactions
1. Stop the transfusion
2. Begin infusion of NS with new tubing.
3. Contact MD and Blood Bank.
4. Continue to monitor patient; especially VS, cardiac, respiratory, and renal function.
5. Return blood and tubing to the blood bank for testing.
Anemia
Lower than normal hemoglobin
A sign of an underlying disorder
Hypo-proliferative Anemia
▪Defective RBC production
• Iron deficiency
• Vitamin B12 deficiency
• Folate Deficiency
Bleeding Anemia
▪RBC loss
Hemolytic Anemia
▪RBC destruction
• Altered erythropoiesis:
• Sickle Cell
• Thalassemia
• Hypersplenism
• Hemolysis
Iron Deficiency Anemia (IDA)
• Highest among non- Caucasian Americans of lower-socioeconomic status
• Can be result of hemorrhage and chronic blood loss
• Insufficient hemoglobin to transport oxygen
Clinical manifestations:
• Fatigue and pallor
• Tachycardia and tachypnea
• Fissures, glossitis, and koilonychias (spoon-shaped nails)
• Decreased HCT & HGB
• Tachypnea & tachycardia
• Shortness of breath
• Blood loss
• Changes in LOC & cognitive impairment
Nursing Management for iron deficiency anemia
• Increase dietary iron
• Increase intake of Vitamin C (aides iron absorption)
• Iron Supplements:
• Oral is first choice. Can cause GI upset.
• IM if severe GI upset with oral.
• IV – can cause CV side effects, so monitoring vital signs is necessary.
• If present minimize blood loss
Vitamin B12 Anemia
Caused by inadequate intake or malabsorption
• Pernicious anemia is a lack of intrinsic factor, so B12 cannot bind, and therefore is not absorbed in the small intestine. (malabsorption)
Daily intake is essential, because B12 is not stored in the body
Required for central nervous system function, RBC formation, and synthesis/regulation of DNA
Cellular metabolism uses b12 for the synthesis of fatty acids and energy production
Clinical Manifestations:
• Neurological deficits
• Fatigue & pallor
• Tachycardia & tachypnea
• Shortness of breath & dizziness
Nursing management for vitamin B12 anemia
Neurological deficits:
• Symmetric paresthesia offeet and fingers
• Coordination and balance problems
• Lhermitte' s sign – electric shock sensation produced by neck flexion.
• Confusion
• Depression
• Impaired taste – stingingsensation on tongue
• Impaired balance
• Mood swings
• Visual disturbances
• Tinnitus – ringing in ears
Actions:
Teach dietary choices
B12 therapy
Assess pain and activity levels due to peripheral neuropathy
Folic Acid Deficiency
Folic acid is a synthetic supplement for Folate, which is naturally found in foods.
Essential for DNA synthesis, cell maturation and replication
Absorbed in the jejunum of small intestine.
Deficiency interferes with formation of heme (oxygen carrying portion of blood)
Nursing Management for folic acid deficiency
Clinical Manifestations
Fatigue & pallor
Tachycardia & tachypnea
Dizziness
Mood changes
Increased bleeding risk
Neurological complications:
Confusion or disorientation
Reversible
Interventions
Ensure intake/administer supplements
Teach dietary choices
Differentiate anemia caused by Folic acid vs. B12
Sickle Cell Anemia
Genetic disorder of hemoglobin
50% of children born with SCA live to adulthood
Complications
Pulmonary infarctions
Cerebrovascular accidents
Infection – *leading cause of hospitalization
More than 90% of people in the United States with SCD are non-Hispanic Black or African American (Black), and an estimated 3%–9% are Hispanic or Latino.
SCD occurs in about 1 out of every 365 Black or African American births and about 1 out of every 16,300 Hispanic American births.
About 1 in 13 Black or African American babies is born with sickle cell trait (SCT, inheritance of a sickle cell gene from only one parent).
3 crisis types
1. Acute vaso-occlusive crisis
2. Aplastic Crisis
3. Sequestration crisis
SCA – Clinical manifestations
Pallor, fatigue, SOB
Pain and swelling due to vaso-occlusion
Pain usually occurs in joints, bones, chest, and abdomen
Ischemic organ damage
Delayed wound healing
Increased risk of infections, particularly respiratory
Hand-foot syndrome
Jaundice
Sickle Cell Anemia Management
During a crisis:
• Oxygen therapy
• Aggressive hydration with oral and parenteral fluids.
• Analgesia – opiates
Exchange blood transfusion
Peripheral stem cell transplantation
Emotional support
Teaching:
• Infection control
• Avoid cold temperatures, tight clothing
• Avoid high altitudes
• Avoid dehydration and overexertion
Aplastic Anemia
Damage to bone marrow resulting in a reduction of all blood cells
Result of diseases or
treatments for diseases
Decrease RBC
• Fatigue, SOB, tachycardia, pallor, dizziness
Decreased WBC
• Increased infection
Thrombocytopenia
• Nosebleed, bruising, bleeding gums
Aplastic Anemia – Nursing Management
Provide O2
Administer blood products
Bleeding precautions
Fall precautions
Teaching:
• Avoid infection
• Monitor temperature
• Avoid risky activities
Polycythemia Vera
Increase in RBC production
Either a genetic tendency or a response to hypoxia
Disease is slow to progress
Hyperviscocity makes it difficult for the heart to pump, leads to
hypoxia
Clinical Manifestations:
SOB
Pruritis, especially after a warm bath
Flushing of the face
Splenomegaly
Polycythemia Vera – Nursing management
Treatment
• Therapeutic phlebotomy
Complications:
• Hyperviscocity leads to increase risk of thrombus.
• Most deaths occur from a heart attack or stroke
• If an injury occurs, there may be hemorrhaging due to a lack of platelets
Actions:
• Increase fluid intake
• Removal of a unit of blood weekly until Hct is <45%, then as needed.
• Routine CBC’s
• Increase rest
• Elevate lower extremities
• Avoid tight clothing and extreme temperatures
Thrombocytopenia
Platelets below normal range (<150,000)
Decreased because of decreased production or platelet destruction.
Heparin Induced Thrombocytopenia (HIT)
Hemorrhagic conditions with thrombocytopenia:
• Hemophilia
• Von Willebrand Disease
Disseminated Intravascular Coagulation
Heparin Induced Thrombocytopenia
Occurs 5-14 days after first administration
Antibodies form against the “foreign” heparin, leads to blood clots and a reduction of platelets
Treatment
• Stop use of Heparin
• DO NOT use Warfarin or platelet transfusions
• Lepirudin and Argatroban are the only anticoagulants approved for treatment
Disseminated Intravascular Coagulation (DIC)
Abnormal blood clotting
Two stages:
• Stage 1: Overactive clotting, all platelets and clotting factors are used, creating thrombi throughout the body.
• Stage 2: Spontaneous bleeding from every orifice due to no platelets/clotting factors
Disseminated Intravascular Coagulation (DIC) causes and treatment
Causes
• Cancer, Sepsis, Pregnancy/Delivery, Injury, Blood transfusion reaction
Treatment:
• Stage 1: Anticoagulants
• Stage 2: Plasma and platelet transfusions, O2 , fibrinogen to replace clotting factors
Bleeding Precautions
1. Soft toothbrush, no flossing
2. Electric razors
3. Shoes or slippers when out of bed
4. Clutter free environment
5. Use stool softener daily (Ex: Docusate)
6. Avoid rectal thermometer, suppositories, enemas, vaginal douches
7. Avoid sexual intercourse if platelet count <50,000
8. Do not blow nose
9. Apply direct pressure and/or ice to lacerations for at least 5 minutes
10. IM injections, arterial sticks, and peripheral blood draws should be minimized
Leukemia
“Blood cancer”
Bone marrow disorder leading to uncontrollable, immature WBC production, known as leukemic/blast cells
Bone marrow, spleen, and lymph tissue congests with blast cells.
4 major types:
• Acute Myeloid Leukemia (AML)
• Chronic Myeloid Leukemia (CML)
• Acute Lymphoblastic Leukemia (ALL)
• Chronic Lymphocytic Leukemia (CLL)
Leukemia Clinical Manifestations
Swollen, painful lymph glands in neck, axillae, groin and left upper abdominal quadrant (spleen location)
Increased risk of infection due to neutropenia
Decrease in RBC’s and platelets due to blast congestion in bone marrow
• Present with symptoms of anemia and thrombocytopenia
Can present with flu like symptoms, but many times asymptomatic
Treatment:
• Chemotherapy and radiation
• Bone marrow transplant
Emergency Situations
• Leukostasis
• Tumor Lysis Syndrome
Leukostasis
WBC count >100,000
Excessive immature WBC
Congestion and organ dysfunction
Mainly in brain, lungs, kidney
Increased risk of bleeding, stroke, dyspnea
Treatment:
• Immediate chemotherapy
• Leukapheresis – removal of WBC
Tumor Lysis Syndrome
treatment
Leads to hyperuricemia, hyperkalemia, hyperphosphatemia
Risk for heart block and tachypnea; renal failure
Treatment:
• Large volume IV fluid administration with diuretics.
•Allopurinol for hyperuricemia
• Dialysis
Complications of Leukemia Treatment
Myelosuppression: suppression of bone marrow activity
• Neutropenia:
High risk of infection
Neutropenic precautions if neutrophil count Is less than 1,000 (Box 34. 2)
• Thrombocytopenia – bleeding precautions (Box 34.1)
Lymph Disorders
Malignant neoplasms originating in the bone marrow and lymphatic system.
HODGKINS LYMPHOMA
Reed-Sternberg (RS-H) cells
Associated with Epstein-Barr Virus and being a 1st degree relative of someone with Hodgkins
Higher survival rate than NHL
Specific manifestations:
• Generalized pruritis
• Alcohol-induced pain
Goal of treatment is cure
NON-HODGKINS LYMPHOMA (NHL)
All other lymphomas that do not have RS-H cells
Associated with Auto-immune disorders and organ transplants
HIV/AIDS, Chlamydia, and Heliobacter pylori increases risk
Evolve mainly from B and T lymphocytes
Goal of treatment is remission
Malignant Lymphoma
Clinical Manifestations
• Painless swelling of the lymph nodes in neck, underarm, and groin.
• Low grade fever for no reason
• Night sweats
• Unexplained weight loss of 10%
• Fatigue
Treatment:
• Chemotherapy and radiation therapy
• Surgical removal of the tumors
• Emergency Situations
• Superior Vena Cava Syndrome
• Spinal Cord Compression
• Tumor Lysis Syndrome
Superior Vena Cava (SVC) Syndrome
Tumor compression of the SVC, causing reduced return of blood flow to the heart and venous congestion.
Dyspnea is most common, edema of the upper body
Treatment:
• Immediate chemotherapy
• Corticosteroids
• SVC stent
Spinal cord compression
Tumor compression of spinal cord.
Symptoms depend on level of compression
Treatment:
• Radiation therapy
• Corticosteroids
Multiple Myeloma
Incurable B-cell malignancy of plasma
Plasma cells create immunoglobulins, which are used in infection control
Malignant plasma cells produce an abnormal antibody: M protein
M protein can cause tumors, bone destruction, kidney damage, and impaired immune function
Risk factors
• Herbicides, insecticides, petroleum, heavy metals, plastics, and radiation
• African Americans
• Males
• Over age 45
Multiple Myeloma
4 classic clinical manifestations
• hyperCalcemia
• Renal dysfunction
• Anemia
• Bone destruction
Multiple Myeloma
Treatment
• No cure
• Chemotherapy
• Bisphosphanates (Ex. Alendronate)
• Encourage fluid intake
RBC’s
“Feed” the body
WBC’s
“Defend” the body
Platelets
“Heal” the body